The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
The Scientist
Most Recent
The release of infectious agents from the lab is not uncommon, but lab-acquired infections are rare.
Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
A drug applied to the ears of deaf mice has prompted the regrowth of noise-damaged hair cells and resulted in slight improvements in the animals’ hearing.
Resource-limited countries are in desperate need of better diagnostic tests for life-threatening illnesses.
Reprogrammed stem cells are not attacked by the immune system, or are they?
Transplanting synthetic stool made of beneficial microbes cures deadly diarrheal infections in two patients.
Researchers uncover weekly and monthly rhythms of sodium retention and excretion in participants of space simulations.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
